MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1.
Feng S, Lu Y, Sun L, Hao S, Liu Z, Yang F, Zhang L, Wang T, Jiang L, Zhang J, Liu S, Pang H, Wang Z, Wang H.
Feng S, et al. Among authors: jiang l.
Ann Transl Med. 2022 Nov;10(21):1171. doi: 10.21037/atm-22-5184.
Ann Transl Med. 2022.
PMID: 36467343
Free PMC article.